Clover Health Investments Corp. Cl A (CLOV): Price and Financial Metrics
GET POWR RATINGS... FREE!
CLOV Price/Volume Stats
| Current price | $0.95 | 52-week high | $3.55 |
| Prev. close | $0.98 | 52-week low | $0.71 |
| Day low | $0.94 | Volume | 5,408,800 |
| Day high | $1.00 | Avg. volume | 6,672,814 |
| 50-day MA | $0.87 | Dividend yield | N/A |
| 200-day MA | $1.39 | Market Cap | 457.99M |
CLOV Stock Price Chart Interactive Chart >
CLOV POWR Grades
- Quality is the dimension where CLOV ranks best; there it ranks ahead of 69.46% of US stocks.
- The strongest trend for CLOV is in Value, which has been heading up over the past 179 days.
- CLOV ranks lowest in Stability; there it ranks in the 5th percentile.
CLOV Stock Summary
- The capital turnover (annual revenue relative to shareholder's equity) for CLOV is 9.69 -- better than 96.08% of US stocks.
- CLOV's price/sales ratio is 0.15; that's higher than the P/S ratio of just 4.4% of US stocks.
- With a year-over-year growth in debt of -78.87%, CLOVER HEALTH INVESTMENTS CORP's debt growth rate surpasses just 2.43% of about US stocks.
- Stocks with similar financial metrics, market capitalization, and price volatility to CLOVER HEALTH INVESTMENTS CORP are RVP, FN, WORX, OPRX, and FRGE.
- Visit CLOV's SEC page to see the company's official filings. To visit the company's web site, go to www.cloverhealth.com.
CLOV Valuation Summary
- In comparison to the median Healthcare stock, CLOV's price/sales ratio is 96.08% lower, now standing at 0.2.
- CLOV's price/earnings ratio has moved up 0.4 over the prior 38 months.
Below are key valuation metrics over time for CLOV.
| Stock | Date | P/S | P/B | P/E | EV/EBIT |
|---|---|---|---|---|---|
| CLOV | 2023-05-23 | 0.2 | 1.5 | -1.5 | -0.9 |
| CLOV | 2023-05-22 | 0.2 | 1.6 | -1.5 | -1.0 |
| CLOV | 2023-05-19 | 0.2 | 1.5 | -1.5 | -0.9 |
| CLOV | 2023-05-18 | 0.2 | 1.6 | -1.5 | -1.0 |
| CLOV | 2023-05-17 | 0.2 | 1.6 | -1.5 | -1.0 |
| CLOV | 2023-05-16 | 0.2 | 1.5 | -1.5 | -0.9 |
CLOV's Quality Factors
The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.- CLOV has a Quality Grade of C, ranking ahead of 33.49% of graded US stocks.
- CLOV's asset turnover comes in at 1.618 -- ranking 5th of 133 Insurance stocks.
- 500 - Internal server error
The table below shows CLOV's key quality metrics over time.
| Period | Asset Turnover | Gross Margin | ROIC |
|---|---|---|---|
| 2021-06-30 | 1.618 | 0.009 | -0.991 |
| 2021-03-31 | 1.251 | 0.098 | -0.276 |
| 2020-12-31 | 1.398 | 0.148 | -0.223 |
| 2020-09-30 | 1.222 | 0.222 | 0.038 |
| 2020-09-30 | 0.000 | NA | -0.006 |
CLOV Price Target
For more insight on analysts targets of CLOV, see our CLOV price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.
| Average Price Target | $9.00 | Average Broker Recommendation | 2.3 (Moderate Sell) |
Clover Health Investments Corp. Cl A (CLOV) Company Bio
Clover Health Investments, Corp. provides health insurance services. The company was founded in 2012 and is based in Franklin, Tennessee.
Latest CLOV News From Around the Web
Below are the latest news stories about CLOVER HEALTH INVESTMENTS CORP that investors may wish to consider to help them evaluate CLOV as an investment opportunity.
Clover Health Investments, Corp. (NASDAQ:CLOV) Q1 2023 Earnings Call TranscriptClover Health Investments, Corp. (NASDAQ:CLOV) Q1 2023 Earnings Call Transcript May 9, 2023 Operator: Ladies and gentlemen, good afternoon, and welcome to the Clover Health First Quarter 2023 Earnings Conference Call. As a reminder, today’s call is being recorded. I would now like to turn the call over to Ryan Schmidt, Investor Relations for Clover […] |
Clover Health Reports First Quarter 2023 Financial ResultsInsurance revenue grew by 14% over Q1’22 Insurance and Non-Insurance MCR improved to 86.6% and 96.1%, respectively Improved 2023 guidance includes Insurance MCR of 87% - 89%, Insurance revenue of $1.18 billion - $1.23 billion, and Adjusted EBITDA of ($125) million - ($175) million FRANKLIN, Tenn., May 09, 2023 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) ("Clover," "Clover Health" or the "Company"), a physician enablement company committed to bringing access to great healt |
Chamath Palihapitiya’s Crumbling SPAC Empire: Where His Top 5 Deals Are TodayNone of the companies the King of SPACs Chamath Palihaitiya took public has made money for investors, although one still has a chance. |
Clover Health to Present at Bank of America 2023 Healthcare Conference on May 11, 2023FRANKLIN, Tenn., May 04, 2023 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) (“Clover,” “Clover Health” or the “Company”), a physician enablement company committed to improving health equity for seniors, today announced that its CFO, Scott J. Leffler, will present at the Bank of America 2023 Healthcare Conference on Thursday, May 11, 2023, at 1:40 p.m. Eastern Time. A live webcast of the presentation will be accessible from Clover Health's investor relations website at https |
Clover Health Announces Agreement to Settle Securities Class Action LitigationFRANKLIN, Tenn., April 24, 2023 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) (“Clover,” “Clover Health” or the “Company”), a physician enablement company committed to bringing access to great healthcare to everyone on Medicare, today announced that the Company has reached an agreement to resolve the securities class action captioned Bond v. Clover Health Investments, Corp. et al., Case No. 3:21-CV-00096 (M.D. Tenn.) (the “securities class action”), which was filed in the w |
CLOV Price Returns
| 1-mo | 28.62% |
| 3-mo | -28.03% |
| 6-mo | -27.48% |
| 1-year | -64.94% |
| 3-year | N/A |
| 5-year | N/A |
| YTD | 2.21% |
| 2022 | -75.01% |
| 2021 | -77.82% |
| 2020 | N/A |
| 2019 | N/A |
| 2018 | N/A |
Loading social stream, please wait...